IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 238 filers reported holding IMMUNOGEN INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,805,000 | -3.0% | 1,500,000 | +15.4% | 3.36% | -7.0% |
| Q2 2023 | $24,531,000 | +401.1% | 1,300,000 | +2.0% | 3.61% | +395.3% |
| Q1 2023 | $4,895,436 | -22.6% | 1,274,853 | 0.0% | 0.73% | -20.7% |
| Q4 2022 | $6,323,271 | -11.8% | 1,274,853 | -15.0% | 0.92% | +4.6% |
| Q3 2022 | $7,170,000 | +6.2% | 1,500,000 | 0.0% | 0.88% | -14.2% |
| Q2 2022 | $6,750,000 | -5.5% | 1,500,000 | 0.0% | 1.02% | -28.3% |
| Q1 2022 | $7,140,000 | -35.8% | 1,500,000 | 0.0% | 1.43% | -36.2% |
| Q4 2021 | $11,130,000 | – | 1,500,000 | – | 2.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |